glp-1 agonists marketing strategies 2025 Australia Receptor Agonist Market Size to Hit USD 2,117.46 Million by 2035 GLP-1 Receptor Agonist Market Forecast
Description
Keywords: Glucagon-like peptide 1 receptor agonists, inflammation, inflammatory bowel disease, neurodegenerative disorder, nuclear factor-kappa B, obesity, type-2 diabetes Introduction Glucagon-like peptide-1 (GLP-1) receptor agonists (GLP-1RA), a category of medications frequently used to treat type 2 diabetes (T2D), comprise drugs such as exenatide, liraglutide, and semaglutide
2023;383 doi: 10.1136/bmj-2022-071027
Back Davenport, HW (1980) 'Robert Kho-Seng Lim (1897-1969): A biographical memoir', National Academy of Sciences
Accessed 12 June 2025
